XML 57 R37.htm IDEA: XBRL DOCUMENT v3.25.0.1

Net revenues (Tables)

12 Months Ended

Dec. 31, 2024

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following table disaggregates revenue by global product category for the years ended December 31, 2024, 2023 and 2022.

			Year Ended December 31,
			2024						2023						2022
Vascular access			$	732,675					$	708,044					$	683,612
Interventional			586,057						511,434						445,018
Anesthesia			395,285						389,957						388,890
Surgical			450,482						427,359						392,917
Interventional urology			331,092						319,785						322,832
OEM			344,511						326,008						272,624
Other (1)			207,222						291,902						285,148
Net revenues (2)			$	3,047,324					$	2,974,489					$	2,791,041

(1) Includes revenues generated from sales of our respiratory and urology products (other than interventional urology products).

(2) The product categories listed above are presented on a global basis, as each of our reportable segments is defined based on the geographic location of its operations.

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration